ZLAB Form 144: 3,000 ADS Sale Scheduled 鈥� $105,000 on 08/08/2025

Q: What does the Form 144 filed for Zai Lab (ZLAB) report?

The filing reports a proposed sale of 3,000 ADS with an aggregate market value of $105,000.00 .

Q: When is the proposed sale scheduled for ZLAB Form 144?

The approximate date of sale listed is 08/08/2025 .

Q: How were the ADS acquired according to the filing?

The ADS were acquired on 12/30/2023 via restricted stock vesting ; the consideration is listed as compensation .

Q: Were there any securities sold in the past three months by the seller?

The filing states "Nothing to Report" for securities sold during the past three months.

Q: On which exchange will the proposed sale be effected?

The filing lists the securities exchange as NASDAQ .

[144] Zai Lab Limited American SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

144

Rhea-AI Filing Summary

What: Form 144 notice related to Zai Lab Limited (ZLAB) reporting a proposed sale of American Depositary Shares (ADS).

Key facts:

Shares to be sold: 3,000 ADS
Aggregate market value: $105,000.00
Approximate sale date: 08/08/2025
Exchange: NASDAQ
Shares outstanding (issuer): 421,725,450

Acquisition: ADS were acquired on 12/30/2023 via restricted stock vesting from the issuer; consideration/ payment listed as compensation.

Other: The filing states "Nothing to Report" for securities sold in the past three months. Some filer/contact fields in the form content are not populated.

Positive

Regulatory compliance: Filing provides required Rule 144 details including acquisition date, nature (restricted stock vesting), and intended sale date
Clear transaction data: Specifies 3,000 ADS, $105,000.00 aggregate market value, and exchange (NASDAQ)

Negative

Insider disposition: Proposed sale by a person for whose account the securities are to be sold is disclosed
Incomplete contact fields: Submission contact and some issuer/filer fields in the provided content appear unpopulated

Insights

TL;DR: Form 144 discloses a proposed sale of 3,000 ADS (aggregate $105,000) scheduled for 08/08/2025; acquisition was restricted stock vesting.

The filing documents a single proposed sale of 3,000 ADS with an aggregate market value of $105,000.00, scheduled for 08/08/2025 on NASDAQ. The ADS were acquired on 12/30/2023 as restricted stock vesting and the payment/consideration is recorded as compensation. The form notes "Nothing to Report" for sales in the prior three months. The disclosure meets Rule 144 reporting requirements by providing acquisition and intended-sale details.

TL;DR: Routine insider disclosure: proposed sale documented with acquisition details; limited additional context or contact data in the provided form content.

The notice specifies the nature of acquisition (restricted stock vesting) and the intended disposition date. The filing indicates no related sales in the prior three months. Within the provided content, several contact and issuer-identifying fields are not populated, which reduces on-form transparency. The document is a routine compliance disclosure rather than a material corporate event in the filing as presented.

08/08/2025 - 12:33 PM

144: Filer Information

Filer CIK

Filer CCC

Is this a LIVE or TEST Filing?

LIVE TEST

Submission Contact Information

Name

Phone

E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold

Name and Address of the Broker

Number of Shares or Other Units To Be Sold

Aggregate Market Value

Number of Shares or Other Units Outstanding

Approximate Date of Sale

Name the Securities Exchange

American Depositary Shares

Fidelity Brokerage Services LLC
900 Salem Street
Smithfield RI 02917

3000

105000.00

421725450

08/08/2025

NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class

Date you Acquired

Nature of Acquisition Transaction

Name of Person from Whom Acquired

Is this a Gift?

Date Donor Acquired

Amount of Securities Acquired

Date of Payment

Nature of Payment *

American Depositary Shares

12/30/2023

Restricted Stock Vesting

Issuer

3000

12/30/2023

Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Source:

FAQ

What does the Form 144 filed for Zai Lab (ZLAB) report?

The filing reports a proposed sale of 3,000 ADS with an aggregate market value of $105,000.00.

When is the proposed sale scheduled for ZLAB Form 144?

The approximate date of sale listed is 08/08/2025.

How were the ADS acquired according to the filing?

The ADS were acquired on 12/30/2023 via restricted stock vesting; the consideration is listed as compensation.

Were there any securities sold in the past three months by the seller?

The filing states "Nothing to Report" for securities sold during the past three months.

On which exchange will the proposed sale be effected?

The filing lists the securities exchange as NASDAQ.

AG真人官方

[144] Zai Lab Limited American SEC Filing

Insights

144: Filer Information

Submission Contact Information

144: Issuer Information

144: Securities Information

144: Securities To Be Sold

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

ATTENTION:

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for Zai Lab (ZLAB) report?

When is the proposed sale scheduled for ZLAB Form 144?

How were the ADS acquired according to the filing?

Were there any securities sold in the past three months by the seller?

On which exchange will the proposed sale be effected?

NASDAQ:ZLAB

ZLAB Rankings

ZLAB Latest News

ZLAB Latest SEC Filings

ZLAB Stock Data

AG真人官方

Trending News

[144] Zai Lab Limited American SEC Filing

Insights

Securities Analyst neutral

Corporate Governance Expert neutral

144: Filer Information

Submission Contact Information

144: Issuer Information

144: Securities Information

144: Securities To Be Sold

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

ATTENTION:

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for Zai Lab (ZLAB) report?

When is the proposed sale scheduled for ZLAB Form 144?

How were the ADS acquired according to the filing?

Were there any securities sold in the past three months by the seller?

On which exchange will the proposed sale be effected?

NASDAQ:ZLAB

ZLAB Rankings

ZLAB Latest News

ZLAB Latest SEC Filings

ZLAB Stock Data